Skip to main content
Published locations for Some PCOS Therapies Cut Cardiovascular Risk : Data on cardiometabolic risk in PCOS treatment show cyproterone acetate to be a 'bad actor.'
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Some PCOS Therapies Cut Cardiovascular Risk : Data on cardiometabolic risk in PCOS treatment show cyproterone acetate to be a 'bad actor.'
User login
Username
Password
Reset your password
/content/some-pcos-therapies-cut-cardiovascular-risk-data-cardiometabolic-risk-pcos-treatment-show
/clinicalendocrinologynews/article/53790/reproductive-endocrinology/some-pcos-therapies-cut
/endocrinology/article/53790/reproductive-endocrinology/some-pcos-therapies-cut-cardiovascular-risk